Hemodialysis And Peritoneal Dialysis Market Size, Share, Opportunities, And Trends By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables), By End-User (Home-based, Hospital-based), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061615918
  • Pages : 152

The hemodialysis and peritoneal dialysis market is estimated to grow at a CAGR of 8.01% during the forecast period.

Dialysis is done when the kidneys are unable to remove toxins from the blood. Hemodialysis is a common kind of blood cleaning procedure that is carried out at any dialysis center three to five times each week. The hemodialysis access is in the patient's arm. Peritoneal dialysis is a type of continuous dialysis that cleans the peritoneal cavity in the abdomen each day to eliminate waste from the blood. It can be done at home. This is accessible through the abdomen. For chronic, or ongoing, dialysis, the patient can get hemodialysis or peritoneal dialysis.

Hemodialysis and peritoneal dialysis market growth prospects

The hemodialysis and peritoneal dialysis industry growth is attributed to a surge in kidney-related illnesses and concerns since kidney transplantation needs a major procedure, a donor match, and a lifetime regimen of immunosuppressant medications to prevent the organ from being rejected from the human body. Further supporting the expansion of the worldwide hemodialysis and peritoneal dialysis market is expected to be the rise in the incidence of chronic diseases and lifestyle-related illnesses including obesity, diabetes, and hypertension. Hemodialysis and peritoneal dialysis industry development is constrained by comparable problems with reimbursement procedures in emerging nations.

Diabetes cases are rising.

According to WHO estimates, adults living with diabetes were most prevalent in the Western Pacific (167 million), South Asia (88 million), and Europe (59 million) in 2021. ERD cases are rising in correlation with rising diabetes incidence. In addition, kidney problems are also caused by poor food, an unhealthy lifestyle, and a lack of physical activity. Lifestyle is responsible for 60% of health-related issues, including malnutrition, smoking, improper food, drug misuse, stress, and alcohol consumption. The aforementioned variables are causing ESRD instances to increase internationally.

Consumables are expected to account for a sizable portion of the industry.

Throughout the projection period, the governments are anticipated to make large expenditures to improve patient safety, patient-centered treatment, and efficacy. Catheters composed of complex materials that are impervious to chemicals like peroxides, iodine, and alcohol are being produced by businesses. Similar to how better surface contact and cutoff membrane dialyzers are for higher diffusion, new production techniques for dialyzers have a positive effect on the expansion of the consumables leading to the growth of the hemodialysis and peritoneal dialysis market. Bloodlines, concentrates, catheters, and other items have been added to the further division of the consumables market.

The dominance of hospital-based dialysis

The dominance of hospital-based dialysis is projected to remain strong in the upcoming years because there is a substantial supply of highly trained and experienced healthcare workers in hospitals. In healthcare settings like dialysis centers and hospitals, the presence of a qualified and skilled renal care team guarantees the best possible care and improved dialysis outcomes. A variety of factors, including the rivals' increased focus on creating independent dialysis facilities and patients' growing acceptance of in-center dialysis, are projected to cause the market to grow. Businesses are also focusing on developing customized hemodialysis equipment with a variety of interventions.

Technological developments

Major factors influencing the hemodialysis and peritoneal dialysis market growth in terms of revenue include technological advancements in dialysis equipment and growing public awareness of the benefits of these treatments. Hemodialysis machines with improved characteristics including portability, usability, and dependability are in high demand. The availability of hemodialysis technology for home use has increased patient satisfaction and offered patients greater independence. Peritoneal dialysis is also gaining popularity as a cost-effective and useful alternative for patients, even though it may be carried out at home without the need for specialized equipment. Additionally, the availability of automated peritoneal dialysis (APD) equipment is likely to fuel hemodialysis and peritoneal dialysis market growth.

Government regulations

Government regulations have been increasing globally fueling the hemodialysis and peritoneal dialysis market growth. For instance, hemodialysis and peritoneal dialysis service providers are required to adhere to quality standards set by the Centres for Medicare & Medicaid Services (CMS). The Food and Drug Administration (FDA) of the United States establishes requirements for hemodialysis and peritoneal dialysis medical devices in terms of their quality, safety, efficacy, and labeling. Before being marketed in the European Union (EU), medical devices must pass several tests to guarantee their quality and safety under the EU Medical Device Directive. Additionally, in Japan, hemodialysis and peritoneal dialysis equipment must adhere to regulations imposed by the Ministry of Health, Labour, and Welfare (MHLW). China has enacted medical device laws that follow both international and domestic standards for hemodialysis and peritoneal dialysis equipment.

Hemodialysis and peritoneal dialysis markets are predicted to increase significantly in North America.

The hemodialysis and peritoneal dialysis market in the area is growing due to the presence of well-known manufacturers, major government expenditures in the development of cutting-edge medical devices, and a supportive reimbursement framework. The prevalence of dialysis is rising due to the rise in kidney failures and Chronic Kidney Diseases (CKD). Increasing healthcare spending, government initiatives, and high disposable income are further factors promoting hemodialysis and peritoneal dialysis market development.

Asia Pacific hemodialysis and peritoneal dialysis market is anticipated to grow

The hemodialysis and peritoneal dialysis market is anticipated to hold a significant market share in the Asia Pacific region during the projected period. Increased development of cutting-edge goods, expanding elderly population, and rising occurrences of renal failure are predicted to promote hemodialysis and peritoneal dialysis market growth over the forecast period. In addition, the IDF estimates that 88 million individuals in Southeast Asia already have diabetes, with 153 million likely to have the disease by 2045. In addition, increased government initiatives, CKD awareness programs, technologically advanced goods, and the existence of recently built state-of-the-art healthcare facilities in the area are a few more factors influencing hemodialysis and peritoneal dialysis market growth.

Market Key Developments

  • In April 2023, a wearable peritoneal dialysis device is being studied in a pre-pivotal clinical investigation by AWAK Technologies and Singapore General Hospital (SGH).
  • In April 2023, Tablo received FDA approval for usage in a variety of locations, including the home and hospital. The user-friendly, interactive touchscreen shows 3-D graphics and conversational instructions to set up the system, administer care, and handle alarms easier.
  • In February 2023, the first central government building for hemodialysis was fitted in New Delhi, India with online hemodiafiltration (HDF) machines, and was inaugurated at Safdarjung Hospital on Wednesday.

Segmentation:

  • By Type
    • Hemodialysis
    • Peritoneal dialysis
  • By Product
    • Device
    • Consumables
  • By End-User
    • Home-based
    • Hospital-based
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

5.1. Introduction

5.2. Hemodialysis

5.3. Peritoneal dialysis

6. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

6.1. Introduction

6.2. Device

6.3. Consumables

7. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END-USER

7.1. Introduction

7.2. Home-based

7.3. Hospital-based

8. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. The Renal Project

10.2. DaVita

10.3. Fresenius Kidney Care

10.4. NephroPlus

10.5. NxStage

10.6. Mayo Clinic

10.7. NephCure

10.8. Fresenius

10.9. Cleveland Clinic


The Renal Project

DaVita

Fresenius Kidney Care

NephroPlus

NxStage

Mayo Clinic

NephCure

Fresenius

Cleveland Clinic